Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

EBCTCG, Petrus Hupperets

Research output: Contribution to journalArticleAcademicpeer-review

1903 Citations (Web of Science)


Background as trials of 5 years of tamoxifen in early breast cancer mature, the relevance of hormone receptor measurements (and other patient characteristics) to long-term outcome can be assessed increasingly reliably. We report updated meta-analyses of the trials of 5 years of adjuvant tamoxifen.
Original languageEnglish
Pages (from-to)771-784
Issue number9793
Publication statusPublished - 2011

Cite this